Clinical course of early and late cytomegalovirus disease in case and control patients
. | Day of CMV disease after transplantation . | Source . | Copathogen present at time of CMV diagnosis . | Death . | Time from CMV diagnosis to death, d . |
---|---|---|---|---|---|
Case patients | |||||
1 | 79 | Pulmo | Pulmonary aspergillosis | No | N/A |
2 | 91 | Pulmo | Pulmonary aspergillosis | No | N/A |
3 | 106 | Pulmo | Candidemia (Candida glabrata) | Yes | 86 |
4 | 111 | Pulmo | No | No | N/A |
5 | 149 | Pulmo | Pulmonary aspergillosis | Yes | 15 |
6 | 153 | GI tract | No | No | N/A |
7 | 161 | BM | No | No | N/A |
8 | 169 | Pulmo | Invasive zygomycosis (sinus) | Yes | 0 |
Mortality | 3/8 (38%) | ||||
Control patients | |||||
1 | 6 | Pulmo | No | Yes | 128 |
2 | 20 | GI tract | No | No | N/A |
3 | 20 | Pulmo | Enterococcus faeciumbacteremia | Yes | 9 |
4 | 24 | GI tract | Streptococcus (NOS) bacteremia | Yes | 342 |
5 | 35 | Pulmo | No | Yes | 0 |
6 | 36 | Pulmo | No | No | N/A |
7 | 36 | Pulmo | No | Yes | 12 |
8 | 50 | Pulmo | No | No | N/A |
9 | 52 | Pulmo | Pulmonary aspergillosis | Yes | 17 |
10 | 58 | GI tract | No | Yes | 86 |
11 | 65 | Pulmo | No | Yes | 13 |
12 | 73 | Pulmo + BM | Escherichia coli bacteremia, pulmonary aspergillosis | Yes | 17 |
13 | 81 | Pulmo | No | Yes | 186 |
14 | 116 | GI tract | No | No | N/A |
15 | 184 | Pulmo | Pulmonary aspergillosis, pulmonary rhizopus, Stenotrophomonas bacteremia | Yes | 28 |
16 | 253 | Pulmo | Pulmonary Pseudomonasaeruginosa | Yes | 21 |
17 | 279 | GI tract | No | No | N/A |
Mortality | 12/17 (71%) |
. | Day of CMV disease after transplantation . | Source . | Copathogen present at time of CMV diagnosis . | Death . | Time from CMV diagnosis to death, d . |
---|---|---|---|---|---|
Case patients | |||||
1 | 79 | Pulmo | Pulmonary aspergillosis | No | N/A |
2 | 91 | Pulmo | Pulmonary aspergillosis | No | N/A |
3 | 106 | Pulmo | Candidemia (Candida glabrata) | Yes | 86 |
4 | 111 | Pulmo | No | No | N/A |
5 | 149 | Pulmo | Pulmonary aspergillosis | Yes | 15 |
6 | 153 | GI tract | No | No | N/A |
7 | 161 | BM | No | No | N/A |
8 | 169 | Pulmo | Invasive zygomycosis (sinus) | Yes | 0 |
Mortality | 3/8 (38%) | ||||
Control patients | |||||
1 | 6 | Pulmo | No | Yes | 128 |
2 | 20 | GI tract | No | No | N/A |
3 | 20 | Pulmo | Enterococcus faeciumbacteremia | Yes | 9 |
4 | 24 | GI tract | Streptococcus (NOS) bacteremia | Yes | 342 |
5 | 35 | Pulmo | No | Yes | 0 |
6 | 36 | Pulmo | No | No | N/A |
7 | 36 | Pulmo | No | Yes | 12 |
8 | 50 | Pulmo | No | No | N/A |
9 | 52 | Pulmo | Pulmonary aspergillosis | Yes | 17 |
10 | 58 | GI tract | No | Yes | 86 |
11 | 65 | Pulmo | No | Yes | 13 |
12 | 73 | Pulmo + BM | Escherichia coli bacteremia, pulmonary aspergillosis | Yes | 17 |
13 | 81 | Pulmo | No | Yes | 186 |
14 | 116 | GI tract | No | No | N/A |
15 | 184 | Pulmo | Pulmonary aspergillosis, pulmonary rhizopus, Stenotrophomonas bacteremia | Yes | 28 |
16 | 253 | Pulmo | Pulmonary Pseudomonasaeruginosa | Yes | 21 |
17 | 279 | GI tract | No | No | N/A |
Mortality | 12/17 (71%) |
CMV indicates cytomegalovirus; GI, gastrointestinal; and BM, bone marrow.